Citations (1)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Khalid Shoumariyeh & Nikolas von Bubnoff. (2014) Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib. Blood and Lymphatic Cancer: Targets and Therapy 4, pages 81-89.
Read now
Read now